Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Biogen Inc (BIIB) vs NetApp Inc. (NTAP) Price & Performance

Biogen IncTrade
NetApp Inc.Trade

Price performance (Past 24H)

Key statistics

Biogen Inc vs NetApp Inc. — how do they compare? Biogen Inc trades at $191.89 (market cap $30.86B), while NetApp Inc. trades at $175.55 (market cap $32.12B). The key difference: Biogen Inc and NetApp Inc. are close in size by market cap, and NetApp Inc. pays a 1.27% dividend while Biogen Inc pays none. Which is the better fit depends on your goals.

BIIBNTAP
Market Cap
$30.86B$32.12B
Sector
HealthTechnology
52-Week High
$216.63$181.08
52-Week Low
$122.68$94.11
Enterprise Value
$33.14B$31.27B
Dividend Yield
1.27%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Biogen Inc

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.

Read more on BIIB

About NetApp Inc.

NetApp is a leading provider of enterprise data management and storage solutions. The company's three operating business units are products, software maintenance, and hardware maintenance. NetApp transitioned from a data center storage firm to a company with software data management solutions for multicloud environments. The California-headquartered company sells globally and has approximately 10,000 employees.

Read more on NTAP